Elevance Health (A58) Stock Statistics & Valuation Metrics
Total Valuation
Elevance Health has a market cap or net worth of EUR 80.99B. The enterprise value is EUR 115.48B.
- Market Cap
- EUR 80.99B
- Enterprise Value
- EUR 115.48B
Share Statistics
Elevance Health has 216,055,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 216,055,900
- Owned by Insiders
- 0.17%
- Owned by Institutions
- 55.34%
Financial Efficiency
Elevance Health’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 6.65%.
- Return on Equity (ROE)
- 0.13
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.65%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 2.06M
- Profits Per Employee
- 58.60K
- Employee Count
- 96,615
- Asset Turnover
- 1.64
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Elevance Health is 17.89. Elevance Health’s PEG ratio is -4.22.
- PE Ratio
- 17.89
- PS Ratio
- 0.45
- PB Ratio
- 2.05
- Price to FCF
- 13.99
- Price to Operating Cash Flow
- 12.03
- PEG Ratio
- -4.22
Income Statement
In the last 12 months, Elevance Health had revenue of 199.13B and earned 5.66B in profits. Earnings per share was 25.18.
- Revenue
- 199.13B
- Gross Profit
- 50.90B
- Operating Income
- 8.11B
- Pretax Income
- 6.71B
- Net Income
- 5.66B
- EBITDA
- 9.66B
- Earnings Per Share (EPS)
- 25.18
Cash Flow
In the last 12 months, operating cash flow was 7.60B and capital expenditures -1.08B, giving a free cash flow of 6.51B billion.
- Operating Cash Flow
- 7.60B
- Free Cash Flow
- 6.51B
- Free Cash Flow per Share
- 29.94
Dividends & Yields
Elevance Health pays an annual dividend of ―, resulting in a dividend yield of 1.56%
- Dividend Per Share
- ―
- Dividend Yield
- 1.56%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 7.15%
- Earnings Yield
- 5.62%
Stock Price Statistics
- Beta
- 0.29
- 52-Week Price Change
- 31.97%
- 50-Day Moving Average
- 359.60
- 200-Day Moving Average
- 319.83
- Relative Strength Index (RSI)
- 51.15
- Average Volume (3m)
- 19
Important Dates
Elevance Health upcoming earnings date is Jan 27, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 21, 2026
- Next Earnings Date
- Jan 27, 2027
- Ex-Dividend Date
- ―
Financial Position
Elevance Health as a current ratio of 1.24, with Debt / Equity ratio of 75.74%
- Current Ratio
- 1.24
- Quick Ratio
- 1.24
- Debt to Market Cap
- 0.42
- Net Debt to EBITDA
- 2.46
- Interest Coverage Ratio
- 5.79
Taxes
In the past 12 months, Elevance Health has paid 1.05B in taxes.
- Income Tax
- 1.05B
- Effective Tax Rate
- 0.16
Enterprise Valuation
Elevance Health EV to EBITDA ratio is 12.56, with an EV/FCF ratio of 17.12.
- EV to Sales
- 0.55
- EV to EBITDA
- 12.56
- EV to Free Cash Flow
- 17.12
- EV to Operating Cash Flow
- 14.68
Balance Sheet
Elevance Health has EUR 37.85B in cash and marketable securities with EUR 30.76B in debt, giving a net cash position of EUR 7.09B billion.
- Cash & Marketable Securities
- EUR 37.85B
- Total Debt
- EUR 30.76B
- Net Cash
- EUR 7.09B
- Net Cash Per Share
- EUR 32.81
- Tangible Book Value Per Share
- EUR 25.62
Margins
Gross margin is 36.55%, with operating margin of 3.69%, and net profit margin of 2.55%.
- Gross Margin
- 36.55%
- Operating Margin
- 3.69%
- Pretax Margin
- 3.10%
- Net Profit Margin
- 2.55%
- EBITDA Margin
- 4.40%
- EBIT Margin
- 3.66%
Analyst Forecast
The average price target for Elevance Health is EUR 427.33, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 427.33
- Price Target Upside
- 14.26% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 14
- Revenue Growth Forecast
- -1.49%
- EPS Growth Forecast
- -9.00%
Scores
- Smart Score
- 5
- AI Score
- ―